Table 4.
Control group | Study group | P value | |
Duration of procedure | 44.0 ± 11.0 | 44.9 ± 9.8 | 0.783 |
Location of fistula creation | - | ||
Dominant | 1 (5.0%) | 0 (0.0%) | |
Non-dominant | 19 (95.0%) | 21 (100.0%) | |
Fistula location | |||
Brachiocephalic | 12 (60.0%) | 13 (61.9%) | > 0.999 |
Snuff-box | 4 (20.0%) | 4 (19.0%) | > 0.999 |
Radiocephalic | 3 (15.0%) | 4 (19.0%) | > 0.999 |
Brachiobasilic | 1 (5.0%) | 0 (0.0%) | - |
Incision length | 3.0 (2.0-5.0) | 3.0 (2.0-5.0) | 0.979 |
Estimated blood loss | 42.5 (20.0-120.0) | 50.0 (10.0-120.0) | 0.530 |
VAS | 4.5 (2.0-10.0) | 2.0 (1.0-8.0) | < 0.001 |
Willingness to repeat the procedure | 3.0 (1.0-9.0) | 8.0 (5.0-10.0) | < 0.001 |
Demand of analgesic | 9 (45.0%) | 3 (14.3%) | 0.069 |
Amount of local analgesic | 22.5 (15.0-38.0) | 20.0 (15.0-40.0) | 0.607 |
Anticoagulant | 14 (70.0%) | 12 (57.1%) | 0.596 |
Beta blocker | 2 (10.0%) | 4 (19.0%) | 0.663 |
Antihypertensive | 10 (50.0%) | 12 (57.1%) | 0.885 |
VAS: Visual analog scale.